General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(MODEST), Milestone pharmaceuticals(MODEST), Sanofi (MODEST), Preventative Cardiovascular Nurses Association(MODEST) RESEARCH/RESEARCH GRANTS: Biocardia(SIGNIFICANT), Abbott(SIGNIFICANT), Evaheart, Inc(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), Ablative Solutions, Inc(SIGNIFICANT), NIH(SIGNIFICANT), nih(SIGNIFICANT), AHA(SIGNIFICANT), PCORI(SIGNIFICANT), NIH(SIGNIFICANT), NIH(SIGNIFICANT), DOD(SIGNIFICANT)

View Full Disclosure